IL17A and diabetic retinopathy: Similarly, a pro-inflammatory phenotype in T1DM patients with diabetic retinopathy was reported, marked by increased production of IL-6, IL-10, and IL-17A by myeloid cells, alongside reduced IFN-γ production by T cells (47).